DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $26.60 million. The enterprise value is $39.37 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 31.32 million shares outstanding. The number of shares has increased by 32.30% in one year.
| Current Share Class | 31.32M |
| Shares Outstanding | 31.32M |
| Shares Change (YoY) | +32.30% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 10.09% |
| Owned by Institutions (%) | 26.07% |
| Float | 25.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.24 |
| Forward PS | 0.47 |
| PB Ratio | 0.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.57 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,406.52 |
Financial Efficiency
Return on equity (ROE) is -74.91% and return on invested capital (ROIC) is -40.23%.
| Return on Equity (ROE) | -74.91% |
| Return on Assets (ROA) | -34.74% |
| Return on Capital (ROIC) | -40.23% |
| Revenue Per Employee | $78,408 |
| Profits Per Employee | -$109,860 |
| Employee Count | 294 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 1.76 |
Taxes
| Income Tax | -1.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.45% in the last 52 weeks. The beta is 1.51, so DarioHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -34.45% |
| 50-Day Moving Average | 0.95 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 34.80 |
| Average Volume (20 Days) | 61,202 |
Short Selling Information
The latest short interest is 1.84 million, so 5.86% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short Previous Month | 1.76M |
| Short % of Shares Out | 5.86% |
| Short % of Float | 7.15% |
| Short Ratio (days to cover) | 25.02 |
Income Statement
In the last 12 months, DarioHealth had revenue of $23.05 million and -$32.30 million in losses. Loss per share was -$0.88.
| Revenue | 23.05M |
| Gross Profit | 14.04M |
| Operating Income | -60.16M |
| Pretax Income | -52.73M |
| Net Income | -32.30M |
| EBITDA | -53.97M |
| EBIT | -60.16M |
| Loss Per Share | -$0.88 |
Full Income StatementBalance Sheet
The company has $15.55 million in cash and $30.49 million in debt, giving a net cash position of -$14.94 million or -$0.48 per share.
| Cash & Cash Equivalents | 15.55M |
| Total Debt | 30.49M |
| Net Cash | -14.94M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | 58.51M |
| Book Value Per Share | 1.87 |
| Working Capital | 10.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$39.17 million and capital expenditures -$200,000, giving a free cash flow of -$39.37 million.
| Operating Cash Flow | -39.17M |
| Capital Expenditures | -200,000 |
| Free Cash Flow | -39.37M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
Gross margin is 60.91%, with operating and profit margins of -260.99% and -205.62%.
| Gross Margin | 60.91% |
| Operating Margin | -260.99% |
| Pretax Margin | -214.05% |
| Profit Margin | -205.62% |
| EBITDA Margin | -234.14% |
| EBIT Margin | -260.99% |
| FCF Margin | -213.65% |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.30% |
| Shareholder Yield | -32.30% |
| Earnings Yield | -132.20% |
| FCF Yield | -161.14% |
Analyst Forecast
The average price target for DarioHealth is $4.00, which is 370.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 370.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 43.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 18, 2019. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Nov 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
DarioHealth has an Altman Z-Score of -5.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.79 |
| Piotroski F-Score | 3 |